Friday, September 6, 2019

What's new in colon cancer?


Colorectal cancer is the second leading cause of cancer death in the United States and the third most common cause of cancer death in the world. Your lifetime risk of developing colorectal cancer is a bit less than 1 in 20.


But there is a light on the horizon. Since 2000, the diagnosis rate for those 50 and older has dropped by a third with recent work on screening and prevention showing how we can improve the numbers even further.


Colon cancer starts in the lining cells of the large intestine in a “two hitprocess.


The first step, theorized to be an exposure to an environmental toxin or infectious agent in a genetically predisposed individual, initiates the rapid growth of a single cell which then, over time, grows into a benign polyp.


A second change then occurs in one of these rapidly growing polyp cells results in the first cell of a colon cancer. If this polyp is removed at this early stage, the small cancer is cured.


Left in place, however, the cancer slowly increases in size until at some point it grows through the wall of the colon. It has been estimated that the time from benign polyp to colon wall cancer is in the neighborhood of 10 years.


This physiology is the basis for screening colonoscopy. Identify and remove polyps and you will prevent, and in some cases, cure colon cancer.


The effectiveness of colonoscopy screening is the likely explanation of the drop in the rate of colon cancer diagnosis over the last 20 years. It has been estimated that over 60% of people over 50 years old have been screened.


The first of the new developments is an easier but equally effective screening test. Advances in immunologic testing allows low risk individuals to collect a small stool sample for testing. Individuals with low risk have no personal or family history of colon cancer or polyps. The stool is then tested for remnants of abnormal proteins shed by polyps. The colonoscopy is reserved to evaluate for and remove polyps only in those who are stool test positive.


This annual fecal immunochemical test (FIT) gives physicians an additional tool to take advantage of that 10 year screening window. More screening equals earlier removal (and cure) of more small colon cancers. The FIT is inexpensive, seemingly as effective as colonoscopy screenings, and more readily available to patients.


The next advance suggests we may be getting closer to the idea of preventing colon cancer rather than just finding it in its early, curable stages. It looks like colon cancer might be an infectious disease.


Thirty years ago, we found that stomach ulcers are often the result of a bacterial infection (H. Pylori) of the digestive tract, rather than the result of acid irritation alone. We now have suggestive evidence that a certain bacteria may be associated with those cell changes that lead to colon polyps and colon cancer.


High concentrations of a family of bacteria (Fusobacterium) were found in colon cancer tissue removed from more than 1000 people at surgery. Even more interesting was finding the same bacteria in an occasional colon metastases (cancer that had spread), implying an even stronger linkage. The benefits of targeting and eliminating this specific colon bacteria (with antibiotics or diet) is being investigated.


And finally, while studying the role of colon bacteria as a cause of colon cancer, there were clues as to how our diet may play a role in the initiation or inhibition of cancerous cell growth. That means making changes in our diet might decrease our personal risk of developing colon cancer.


It’s old news that vegetarians have less colon cancer, 20 - 30 percent less than non-vegetarians. But why?


One possibility could be the elimination of a cancer cell stimulant. Studies of groups on high versus low meat diets revealed a three fold variation in the concentration of nitrosamines, a potentially cancer causing compound, in their stool.


Another might be the addition of an actual inhibitor of cancer growth. The microbiome produces short-chain fatty acids as it metabolizes dietary fiber. Laboratory experiments exposing colon cancer cells to one of them, butyrate, slows and can even stop cancer cell growth. Take away the butyrate and the cells resume growing.


More fruits and vegetables, less red meat, and it appears you can impact your colon cancer risk.


Even after colon cancer’s development, diet changes impact a patient’s future course. In a study of 1,000 people already diagnosed with colon cancer spread beyond the colon, those who modified their lifestyle to a healthier diet with added exercise decreased their risk of dying over the next seven years. The risk was decreased by 42 percent compared to those who did not change their diet.



Better screening, prevention with simple diet changes, and the chance that we might eliminate one reason for that first cancer cell are three reasons I’m optimistic that the trend line for colon cancer diagnosis (and deaths) will continue on a downward trend.

References:











Aspirin may decrease CRC by its effect on the microbiome. https://www.medscape.com/viewarticle/937141

Egg and colon cancer risk via TMAO

Less meat/alcohol and more dairy = less colon cancer

https://www.medscape.com/viewarticle/958688